Trial intelligence / Profile preview

Hormonal Add-Back Therapy in Adolescents With Endometriosis

NCT00474851Phase 2Completed

Sponsor
Boston Children's Hospital
Start
Aug 2007
Primary completion
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of conjugated estrogens in endometriosis (2 arms), sponsored by Boston Children's Hospital. Primary endpoint: Bone Mineral Density at 12 months. Started Aug 2007; status: completed.

02

Drugs

conjugated estrogens
03

Conditions

endometriosis

Beyond the preview

Go deeper on NCT00474851.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00474851.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call